secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innovation Pharmaceuticals Inc. (—)
CIK:        0001355250
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001477932-23-007971
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Innovation Pharmaceuticals changes independent auditor from Pinnacle to GreenGrowth CPAs
--------------------------------------------------------------------------------

- On October 29, 2023, the Audit Committee dismissed Pinnacle Accountancy Group as the company's independent auditor, effective immediately.
- The company engaged GreenGrowth CPAs as its new independent public accounting firm on the same date.
- The change followed the sale of a portion of Pinnacle's public company accounting practice to GreenGrowth.
- Pinnacle's reports for fiscal years ended June 30, 2023 and 2022 were unqualified except for a going concern explanatory paragraph.
- The company reported a material weakness in internal control over financial reporting related to an unconsolidated foreign investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/0001477932-23-007971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1355250/000147793223007971/ipix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-007971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer